Efficacy of Topiramate in the treatment of Schizophrenia
Phase 3
- Conditions
- Schizophrenia.Schizophrenia
- Registration Number
- IRCT201303287373N3
- Lead Sponsor
- Arak University Medical of Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
age range 15-50 ;diagnosis of schisophrenia according to DSM4-TR criteria and clinical interview by psychiatrist ; informed written consent letter; a score of at least 60 in PANSS
Exclusion criteria :pregnancy;lactation; substance abuse;severe physical disease;epilepsy;use of Antiepileptic drugs ;contraindication of Topiramate
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PANSS. Timepoint: before intervention and every 4 weeks. Method of measurement: clinical examination.
- Secondary Outcome Measures
Name Time Method Extrapyramidal side effects. Timepoint: before intervention and every 4 weeks. Method of measurement: clinical examination.